2nd annual CO #LymphWalk to kick off June 3, 8am, Sloan’s Lake Park, Denver

Allyson Hannah to keynote 2018 CO LymphWalk

Allyson Hannah to keynote 2018 CO LymphWalk

Neika Rosenberger to sing National Anthem at 2018 CO LymphWalk

Neika Rosenberger to sing National Anthem at 2018 CO LymphWalk

Join the Fight at the 2nd annual CO LymphWalk

Join the Fight at the 2nd annual CO LymphWalk

Local advocates to keynote and to sing National Anthem; Klose Training to receive LE&RN Impact Award

I am thrilled to have the opportunity to sing our National Anthem at the LE&RN Colorado LymphWalk, and to be involved with such an important and too-often-ignored cause, fighting LE and LD.”

— Neika Rosenberger, National Anthem singer, LE&RN CO 2018 #LymphWalk

DENVER, CO, USA, May 25, 2018 /EINPresswire.com/ — Join the Colorado Chapter of the Lymphatic Education & Research Network (LE&RN) for the second annual Colorado Run/Walk to Fight Lymphedema & Lymphatic Diseases; just register or donate at www.LymphWalk.org. While LE&RN marks 20 years of fighting lymphedema (LE) and lymphatic diseases (LD) on behalf of the estimated 10 million Americans and 170 million worldwide who are fighting this Lymphedemic®, the LE&RN Colorado Chapter celebrates the 2nd year of this successful and inspiring #LymphWalk.

This year’s speaker is Allyson Hannah, born with primary LE in her left leg. Raised in Colorado, she is excited to speak and advocate for LE/LD in her home state. Allyson graduated this past December from Colorado State University with a degree in Sociology and minors in Spanish and International Studies. After a semester in Peru, she has become an avid traveler and wants others with LE to know that they too can live an active lifestyle. Beyond traveling, Allyson enjoys yoga, painting, attending local shows, volunteering in the community, and telling everyone how to manage LE/LD in order to live a full life.

Neika Rosenberger will sing the National Anthem at the start of this year's Run/Walk. "I am thrilled to have the opportunity to sing our National Anthem at the LE&RN Colorado LymphWalk, and to be involved with such an important and too-often-ignored cause, fighting LE and LD," Neika said. Neika has a BA in music from Colorado College and can often be seen performing with Opera Theatre of the Rockies and the Colorado Springs Fine Arts Center. When not performing herself, she enjoys teaching young people to perform, including her son, Jude.

A 2018 LE&RN Impact award will be presented to Klose Training at the event.

The Colorado Chapter of LE&RN thanks local Run/Walk sponsors: Klose Training, DJ Drake, Body Works Compression, The Women’s Clinic of Northern Colorado, and Huntington Properties, LLC. In-Kind donations provided by King Soopers, West + Main Homes, and American Pacific Mortgage. Raffle items donated by Colorado Avalanche, Sloan’s Lake Tap & Burger, Sam’s No. 3, 7Cellars by John Elway, Murray-Brothers Creations, as well as friends and family.

LE&RN thanks National Walk Sponsors Jobst (Premier National Sponsor), Tactile Medical (Presenting Sponsor), Eiger BioPharmaceuticals, Herantis Pharma, ImpediMed/L-Dex, Juzo, Sigvaris, Bio Compression Systems, L&R USA, MediUSA, Lympha Press, and LympheDIVAS.

About LE&RN
Founded in 1998, the Lymphatic Education & Research Network (formerly LRF) is a 501(c)(3) not-for-profit organization whose mission is to fight lymphatic disease and lymphedema through education, research, and advocacy. LE&RN provides valuable educational resources for the millions of people who suffer from lymphedema and lymphatic disease. LE&RN fosters and supports research that can deepen the medical community's understanding of the lymphatic system. For more information about lymphatic diseases or the Lymphatic Education & Research Network, please visit www.LymphaticNetwork.org or call (516) 625-9675.

Laura Farrell
Lymphatic Education & Research Network
(516) 625-9675
email us here


Source: EIN Presswire

SMi to host 2 sell-out Conferences in San Diego this June; Pre-Filled Syringes and Pharmaceutical Microbiology

SMi Reports: Pre-Filled Syringes West Coast and Pharmaceutical Microbiology West Coast conferences to be hosted this June in San Diego

LONDON, UNITED KINGDOM, May 25, 2018 /EINPresswire.com/ — San Diego is set to host industry experts in the fields of Pre-Filled Syringes and Pharmaceutical Microbiology at the beginning of next month on June 4th – 5th and June 7th – 8th respectively.

These highly anticipated conferences promise to provide attendees with over 30 experts presenting on the latest updates, challenges and futures of pre-filled syringes and pharmaceutical microbiology. The events will boast over 20 exhibitors, including Roche, Mitsubishi Gas Chemical, Fujifilm, Worrell, Nemera, Novatek and many more, showcasing their impressive portfolio of pharmaceutical products.

Over 150 attendees are confirmed to be joining the conferences, where they will gain insights into optimizing and developing novel industry methods from design to distribution at Pre-Filled Syringes West Coast. Pharmaceutical Microbiology West Coast is set to deliver updates to attendees and promote discussion on the key challenges and developments within the pharmaceutical microbiology industry.

Participants will advance their knowledge in the two industries over the course of less than a week, having the opportunity to develop their skills and network with big pharma companies, academics, scientific pioneers and experts, all under one roof.

The highlights of the two-day conference on Pre-Filled Syringes West Coast include:

• An overview of the challenges of biopharmaceutical manufacturing in the pre-filled syringes industry
• Exploring the options, approaches and future trends of the container and closure integrity testing
• Learning how to engage with product teams, both clinical and commercial, early on to identify unmet needs and opportunities
• Discussing the future of pre-filled syringe injection devices, with representatives from AbbVie, Pfizer, Genentech, Ferring Pharmaceuticals, MedImmune, Amgen and many more, debating the upcoming challenges and important changes in the industry

At the Pharmaceutical Microbiology West Coast event, attendees can expect two days of 5+ hours of networking with industry experts, and 16+ hours of in-depth presentations, which will include:

• A focus on data integrity and aseptic processing with keynotes from Shire, Charles River, Microrite and GXP consultants
• Examining the underlying issues behind microbiological deviations and the impact on data integrity
• Hands-on training through two half-day, pre-conference interactive workshops:
o Workshop A: A practical guide to “Risk Based Environmental Monitoring” that addresses real world risk of contamination control
o Workshop B: Technologies for Microbial Contamination Control

Visit the event websites to download the updated programmes, speaker line-ups and list of attending companies at:

www.prefilled-syringes-westcoast.com/einpr

www.pharma-microbiology-usa.com/einpr

Interested in sponsoring, exhibiting or speaking at these events?
Contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk

Pre-Filled Syringes West Coast
4th – 5th June 2018
Crowne Plaza San Diego, USA
www.prefilled-syringes-westcoast.com/einpr
#smipfsusa

Pharmaceutical Microbiology West Coast
7th – 8th June 2018
Crowne Plaza San Diego, USA
www.pharma-microbiology-usa.com/einpr
#pharmamicrousa

—- END —-

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at www.smi-online.co.uk

Luda Durneva
SMi Group
+44 (0)20 7827 6000
email us here


Source: EIN Presswire

Cancer Biological Therapy Market Analysis 2018 (By Segment, Key Players and Applications) and Forecasts To 2023

Cancer Biological Therapy Industry 2018- By Plan Future Business Decisions Using the Forecast Figures

PUNE, INDIA, May 25, 2018 /EINPresswire.com/ — Biological therapy treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such content. There are various types of biological therapies, which inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

The global cancer biological therapy market is expected to reach USD 82,276.8 million by 2023 at a CAGR of 4.7% during the forecasted period.
The global cancer biological therapy market is segmented on the basis of phases, types, end users and regions. On the basis of phases, the market is segmented into phase I, phase II and phase III. In stage I & II the real impact of these therapies is seen and giving a success rate of 35% in Phase 1 and 20% in Phase II. The success rate of phase I is 35%.
On the basis on types, the global cancer biological therapy market is segmented into monoclonal antibodies, cancer growth blockers, interferons, interleukins, gene therapy, targeted drug delivery, colony stimulating factor, cancer vaccines and others. Monoclonal antibodies accounted for the largest market share of the global cancer biological therapy market. Colony stimulating factor is the fastest growing market at a CAGR of 5.2% during the forecasted period.
On the basis on end users, hospitals & clinics dominates the global cancer biological therapy market. Registering USD 26,790.6 million in 2016 and expected to reach at USD 38,471.9 million by 2023 at the rate of 4.4 % from 2016-2023.
On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and the Middle East & Africa. North America has the dominating market for cancer biological therapy. The cancer biological therapy market for North America is estimated at USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%.

Key Players
The leading market players in the global cancer biological therapy market include Merck Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Amgen Inc., Bristol-Myers Squibb, Celgene, ELI Lilly and Company, EnGeneIC, and Pfizer

Study objectives
• To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global cancer biological therapy market
• To provide insights about factors influencing and affecting the market growth
• To provide historical and forecast revenue of the market segments and sub-segments with respect to countries
• To provide historical and forecast revenue of the market segments based on channels, applications, and regions for the global cancer biological therapy market.
• To provide strategic profiling of key players in the market, and comprehensively analysing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economical factors that influences the global cancer biological therapy market
• To provide detailed analysis of the value chain and supply chain of the global cancer biological therapy market

Target Audience
• Pharmaceutical Companies
• Pharmaceutical Suppliers
• Cancer Research Organizations
• Potential Investors
• Key Executive (CEO and COO) and Strategy Growth Manager
• Reaserch Companies

Key Findings
• North America accounted for the largest market share in the global cancer biological therapy market, USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%
• Colony stimulating factor is the fastest growing segment with a CAGR of and 5.2% in the global cancer biological therapy market, by types
• Hospitals and clinics is contributing remarkable share in the market registering 47.8% in the global cancer biological therapy market, by end users in 2016

Table of Content: Key Points
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Cancer Biological Therapy Market, by phases
7 Global Cancer Biological Therapy Market, by Application
8 Global Cancer Biological Therapy Market, by End Users
9 Global Cancer Biological Therapy Market, by Region
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Microdermabrasion Market Analysis 2018 (By Segment, Key Players and Applications) and Forecasts To 2023

Microdermabrasion – Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2023

PUNE, INDIA, May 25, 2018 /EINPresswire.com/ — Introduction
Microdermabrasion is a popular technique for the treatment of various skin conditions like acne, hyperpigmentation, trauma scars, photo-damage, stretch marks, and others. Increasing prevalence of skin diseases, rising demands for minimally invasive aesthetic procedures, growing expenses on the cosmetics are the major drivers for the market growth. However, alternative non-surgical procedures in the market may restrain the market growth during the forecast period. The global market for microdermabrasion segmented on the basis of type, product, indication, end user, and region.
The market for microdermabrasion, by type is segmented into diamond microdermabrasion, crystal microdermabrasion, and others. The diamond microdermabrasion segment accounted for the largest market share in 2016.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3060928-global-microdermabrasion-market-research-report-forecast-to-2023

The microdermabrasion market is further segmented on the basis of product. The product segment is sub-segmented into the microdermabrasion machine, microdermabrasion crystals, microdermabrasion tips, microdermabrasion creams and scrubs, and others. Microdermabrasion machine segment accounted for the largest market share in 2016, and is expected to be the fastest growing segment which is expected to grow at a CAGR of 3.68%.
On the basis of indication, the global microdermabrasion market is segmented into hyperpigmentation, acne & trauma scars, photo-damage, stretch marks, and others. Acne & trauma scars segment accounted for the largest market share in 2016 which is valued at USD 194.30 million.
On the basis of end users, the global microdermabrasion market is segmented into hospitals, dermatology clinics, home care, and others. Hospitals segment accounted for the largest market share in 2016. The market for home care was around USD 124.22 million in 2016.

Key Players
The key players for the microdermabrasion market are Johnson & Johnson Services Inc., Procter & Gamble, Koninklijke Philips N.V., Altair Instruments, Silhouet-Tone, Advanced Microderm, Inc., Dermaglow, New Shining Image LLC., Lasertec Medical Service, Delasco, and others.

Study objectives
• To provide insights about factors influencing and affecting the market growth
• To provide historical and forecast revenue of the market segments and sub-segments with respect to countries
• To provide historical and forecast revenue of the market segments based on type, product, indication, end user and region for the global microdermabrasion
• To provide strategic profiling of key players in the market, and comprehensively analysing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economical factors that influences the global microdermabrasion
• To provide detailed analysis of the value chain and supply chain of the global microdermabrasion

Target Audience
• Pharmaceutical and Biotech Industries
• Potential Investors
• Medical Research Institutes
• Key Executive (CEO and COO) and Strategy Growth Manager
• Research Companies

Key Findings
• The key players involved in this strategy are Koninklijke Philips N.V., Johnson & Johnson Services Inc., Procter & Gamble, Altair Instruments, Aesthetic Solutions Inc, Advanced Microderm, Inc., and Silhouet-Tone. Koninklijke Philips N.V. holds 18.0% of the total microdermabrasion market
• Acne & trauma scars segment, by indication accounted for the largest market share in 2016 which is valued at USD 194.30 million
• On the basis of end user, the market for home care was USD 124.22 million in 2016.
• On the basis of region, Asia Pacific region is projected to be the fastest growing region, at a CAGR of 19.91% during the forecast period.

Table of Content: Key Points
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Microdermabrasion Market, By Type
7 Global Microdermabrasion Market, By Product
8 Global Microdermabrasion Market, By Indication
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/3060928-global-microdermabrasion-market-research-report-forecast-to-2023

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Blood Bank Information System 2018 Global Market Outlook,Research,Trends and Forecast to 2025

WiseGuyReports.Com Publish a New Market Research Report On –“ Blood Bank Information System 2018 Global Market Outlook,Research,Trends and Forecast to 2025”.

PUNE, INDIA, May 25, 2018 /EINPresswire.com/ —

In this report, the global Blood Bank Information System market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Blood Bank Information System in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/3195148-global-blood-bank-information-system-market-research-report-2018

For more information or any query mail at sales@wiseguyreports.com

Global Blood Bank Information System market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Roper Industries
Haemonetics
Cerner Corporation
McKesson
Mak-System
Integrated Medical Systems
Mediware
Compugroup
SCC Soft Computer
Zhongde Gaoye
Blood Bank Computer Systems
Jinfeng Yitong
Fengde
IT Synergistics
Psyche Systems

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Blood Donor Management Module
Blood Bank Transfusion Service Module
Other

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Blood Station
Hospital

Report Details @ https://www.wiseguyreports.com/reports/3195148-global-blood-bank-information-system-market-research-report-2018

Table Of Contents – Major Key Points

Global Blood Bank Information System Market Research Report 2018
1 Blood Bank Information System Market Overview
1.1 Product Overview and Scope of Blood Bank Information System
1.2 Blood Bank Information System Segment by Type (Product Category)
1.2.1 Global Blood Bank Information System Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Blood Bank Information System Production Market Share by Type (Product Category) in 2017
1.2.3 Blood Donor Management Module
1.2.4 Blood Bank Transfusion Service Module
1.2.5 Other
1.3 Global Blood Bank Information System Segment by Application
1.3.1 Blood Bank Information System Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Blood Station
1.3.3 Hospital
1.4 Global Blood Bank Information System Market by Region (2013-2025)
1.4.1 Global Blood Bank Information System Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Blood Bank Information System (2013-2025)
1.5.1 Global Blood Bank Information System Revenue Status and Outlook (2013-2025)
1.5.2 Global Blood Bank Information System Capacity, Production Status and Outlook (2013-2025)

…….

7 Global Blood Bank Information System Manufacturers Profiles/Analysis
7.1 Roper Industries
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Blood Bank Information System Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Roper Industries Blood Bank Information System Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Haemonetics
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Blood Bank Information System Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Haemonetics Blood Bank Information System Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Cerner Corporation
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Blood Bank Information System Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Cerner Corporation Blood Bank Information System Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 McKesson
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Blood Bank Information System Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 McKesson Blood Bank Information System Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Mak-System
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Blood Bank Information System Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Mak-System Blood Bank Information System Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.5.4 Main Business/Business Overview
7.6 Integrated Medical Systems
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Blood Bank Information System Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Integrated Medical Systems Blood Bank Information System Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Mediware
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Blood Bank Information System Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Mediware Blood Bank Information System Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Compugroup
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Blood Bank Information System Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Compugroup Blood Bank Information System Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview

Continued…..

For more information or any query mail at sales@wiseguyreports.com

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

HIV Vaccines 2018 Global Market Challenge, Driver, Trends & Forecast to 2027

HIV Vaccines Market – What's New Trending For 2018 – 2027?

PUNE, INDIA, May 25, 2018 /EINPresswire.com/ — Introduction
Vaccines empower the human immune system to protect against infection or disease. Vaccines against HIV are being developed, and tested in phases of clinical trials. At present, none of the HIV vaccines are commercially available.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/860844-global-hiv-vaccines-market-development-and-forecast-to-2027

More than 30 HIV candidate vaccines have been tried in roughly 60 Phase I/II trials, involving more than 10,000 healthy volunteers. A large portion of these trials have been conducted in the United States & Europe, and a few in developing countries such as Brazil, Peru, China, and Thailand. The outcomes have affirmed the safety of the vaccines, and have given important scientific information to create fresher eras of candidate vaccines with better capacity to induce anti-HIV specific immune responses.

GET SAMPLE REPORT @

This research report provides in-depth information about the various market segments. It shall also provide qualitative information about the current and upcoming trends in HIV vaccines market, globally.
The market is majorly divided on the basis of phases of clinical trials and regions. Globally, North America commands the largest market share of around 44% of the global market. This large share is majorly attributed to high adoption of various HIV vaccine trials coupled with the technological advancement in the region. North America is one of the important partners for HIV prevention & research for the development of HIV vaccine, as well as for reduction and prevention of HIV. It has been revealed that more than $600 million a year is invested into HIV vaccine R&D, with the major share coming from the US National Institutes of Health. United States was the first country to carry out the first Phase I trial of an HIV candidate vaccine in 1987. Since then, more than 30 distinctive candidate vaccines have been developed by many organizations, utilizing various technologies mostly in the United States.

Growing number of market players, increasing awareness about HIV prevention among various nations, rising prevalence of HIV, and rising funds for HIV vaccines research, are some of the key factors propelling the growth of HIV vaccines market. However, hindrance during HIV vaccine approval process is limiting the market growth to a great extent.

Some of the key players of the market are GlaxoSmithKline plc (U.K.), SANOFI (France), Argos Therapeutics, Inc. (U.S.), Bionor Pharma ASA (Norway), Janssen Global Services, LLC (U.S.), GENECURE LLC (U.S.), GeoVax (U.S.), GENVEC, INC. (U.S.), PaxVax Corporation (U.S.), and Inovio Pharmaceuticals, Inc. (U.S.).

STUDY OBJECTIVES OF HIV VACCINES MARKET DEVELOPMENT AND FORECAST TO 2027
• To provide insights about factors, influencing and affecting the market growth
• To provide present and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries
• To provide present as well as forecast revenue of the market segments based on products, and sub-segments for global HIV vaccines market
• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic and ethical factors that influences the global HIV vaccines market

Target Audience
• Pharmaceutical companies
• Research Laboratories
• Hospitals & Clinics
• Service Suppliers
• Potential Investors
• Key executive (CEO and COO) and strategy growth manager

Key Findings
• The global HIV vaccines market is expected to grow at a CAGR of 5.0% between 2017 and 2027, driven by growth from both developed and emerging markets
• North America contributed more than 44% of the total market size in 2017. Emerging markets such as China and India are expected to generate significant demand for HIV vaccines during the period, 2017-2027
As per the analysis, the global HIV vaccines market is expected to reach $2.7 billion by 2027. The market in Europe is estimated to be around $ 437 million in 2017 and is anticipated to reach $ 757 million by 2027. Asia-Pacific is expected to grow at a moderate pace during the forecast period.

Table of Content: Key Points
1 REPORT PROLOGUE 9
2 INTRODUCTION 11
3 RESEARCH METHODOLOGY 13
4 MARKET DYNAMICS 15
5 MARKET FACTOR ANALYSIS 19
6 GLOBAL HIV VACCINE MARKET, BY CLINICAL TRIALS 20
7 GLOBAL HIV VACCINE MARKET, BY REGION 22
8 COMPETITIVE LANDSCAPE 27
9 COMPANY PROFILE 32
…Continued
ACCESS REPORT @ https://www.wiseguyreports.com/reports/860844-global-hiv-vaccines-market-development-and-forecast-to-2027

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Facial Injectable Market Key players like Merz Pharma, Valeant, Integra LifeSciences are making huge investment

Global Facial Injectable Market Research Report 2018 Analysis and Forecast to 2021

PUNE, INDIA, May 25, 2018 /EINPresswire.com/ — Introduction
Facial Injectable products, also known as dermal fillers are products that help in trending applications such as bioengineering or facial rejuvenation. With age, facial skin is bound to lose subcutaneous fat naturally and the skin is lured closer to the facial working muscles, thereby making smile lines and wrinkles over the face, more visible. This also leads to stretching of facial skin which adds to the loss of volume. These issues can be solved with the use facial injectable or dermal fillers. These products may also be used in treating early signs of ageing or as a value addition to a facial rejuvenation surgery.
The global facial injectable market is expected to reach USD 9.0 billion by 2021, growing at 13.2% CAGR during the forecast period.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/877779-global-facial-injectable-market-estimation-forecast-2013-2021

On the basis of type, the global facial injectable market is segmented into botulinum toxin, hyaluronic acid, polymers & particles, and collagen. Botulinum toxin segment is estimated to hold the largest share within the global facial injectable market in 2016.
The market has been segmented on the basis of geography into North America, Europe, Asia-Pacific, and Middle East & Africa. North America is estimated to hold the largest market share of around 40% in 2016, while Asia-Pacific market is projected to register the fastest growth of 13.6% CAGR during the forecast period.

Key Players
The leading players of the global facial injectable market are Galderma S.A. (Switzerland), ALLERGAN (Ireland), Merz Pharma (Germany), Valeant (Canada), and Integra LifeSciences Corporation.(U.S.).

Study Objectives
• To provide insights about factors influencing and affecting the market growth
• To provide historical and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries
• To provide historical and forecast revenue of the market segments based on type, application, and end-users
• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

Target Audience
• Pharmaceutical companies
• Cosmetic Surgery Centers
• Potential Investors
• Raw Material Suppliers
• Key executive (CEO and COO) and strategy growth manager

Key Findings
• North America market is projected to reach USD 3.4 billion by 2021, growing at the rate of 12.6% CAGR during the forecast period
• Asia-Pacific region is estimated to be valued at USD 786.7 million in 2016, and is expected to reach USD 1.6 billion by 2021
• Europe commands the second largest share of around 33% of global market in 2016

Table of Content: Key Points
1 MARKET OVERVIEW 12
2 RESEARCH METHODOLGY 17
3 MARKET DYNAMICS 19
4 GLOBAL FACIAL INJECTABLE MARKET BY REGIONS 27
5 COMPETITIVE LANDSCAPE 75
6 GLOBAL FACIAL INJECTABLE MARKET: COMPANY PROFILE 77
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/877779-global-facial-injectable-market-estimation-forecast-2013-2021

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Bone Cancer Diagnosis and Therapeutics Market 2018 Trends, Research, Analysis & Review Forecast 2023

PUNE, MAHARASHTRA, INDIA, May 25, 2018 /EINPresswire.com/ — Global Bone Cancer Diagnosis and Therapeutics Industry

New Study on “2018-2023 Bone Cancer Diagnosis and Therapeutics Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

The global bone cancer diagnosis market is anticipated to grow at a CAGR of 7.8% by 2023. Several factors such as exposure towards radiation, factures, treatment for certain cancer related drugs, and genetic disorders cause bone cancer. Robust healthcare expenditure in developed countries, genetic disorder, and development of stem cell transplant technology are some of the major factors that drive the growth of the market. Rising geriatric population is one of the major factors that contribute to the growth of the market as several diseases rise with aging. The increase in the prevalence of the Paget diseases and others are the factors that are driving the market. Major symptoms of bone cancer include pain, swelling, and fractures. When the bone cancer develops in a bone, the bone weakens.

Try Sample Report @    https://www.wiseguyreports.com/sample-request/3186924-global-bone-cancer-diagnosis-and-therapeutics-market-research

According to the Cancer Research UK organization, 580 new cases of bone sarcoma were found in the UK during 2014. The occurrence rate of bone sarcoma is anticipated to fall by 5% in the UK by 2035, to 1 case for each 100,000 individuals by 2035. 1 in every 1,140 men and 1 out of 1,660 women will be determined to have bone sarcoma amid their lifetime. The bone cancer diagnosis and therapeutics market has been segmented on the basis of type, therapies and end users. On the basis of type, the market has been segmented into primary bone cancer and secondary bone cancer. The primary bone cancer has been further bifurcated into osteosarcoma, chondrosarcoma, Ewing’s sarcoma, Spindle cell sarcoma, and chordoma. Based on diagnosis, the market has been bifurcated into MRI scan, X-rays, CT-scan, Radionuclide bones scans, biopsy and others. On the basis of therapies, the market has been bifurcated into radiation therapies, chemotherapy, cryosurgery, surgical treatment, targeted therapy and others. According to end user, the market has been segmented into multispecialty hospitals and cancer research centers.

Geographically, the worldwide bone cancer diagnosis and therapeutics showcase is divided into North America, Europe, Asia-Pacific, and Rest of the World. Asia Pacific market is considered to be the fastest growing market globally. The rise in number of cancer patients in the APAC region is considered to rise eventually enabling bone cancer diagnosis and therapeutics market to grow. North America and Europe are considered to be the dominating markets due to various factors such as high healthcare expenditure, development in technology, support from government, rising key market players fuel the growth of the market.

The key players in the bone cancer diagnosis and therapeutics market Include Ablynz, Allergan, Aveo pharmaceuticals, Inc., Amgen Inc., Amura Holdings Ltd., Bayer AG, Catena pharmaceuticals Inc., Celldex therapeutics, Debiopharma Group, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Galapagos NV, Infinity Pharmaceuticals, Medivir AB, Merrion Pharmaceuticals Plc., Novartis AG, Pfizer, Inc. These are the key strategic players of bone cancer diagnosis and therapeutics.

MARKET SEGMENTATION: 
Global bone cancer diagnosis and therapeutics market is segmented on the basis of, type, by therapies, by diagnosis, by end user and regional outlook.

Global Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, By Type 
Global Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, By Therapies 
Global Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, By Diagnosis 
Global Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, By End User 
Global Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, By Region 
The Report covers: 
Comprehensive research methodology of Global Bone cancer diagnosis and therapeutics 
This report also includes detailed and extensive market overview with key analyst insights. 
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. 
Analysis of regional regulations and other government policies impacting the Global Bone cancer diagnosis and therapeutics 
Insights about market determinants which are stimulating the Global Bone cancer diagnosis and therapeutics 
Detailed and extensive market segments with regional distribution of forecasted revenues. 
Extensive profiles and recent developments of market players.

 Some points from table of content:

1. REPORT SUMMARY 
1.1. RESEARCH METHODS AND TOOLS 
1.2. MARKET BREAKDOWN 
1.2.1. BY SEGMENTS 
1.2.2. BY GEOGRAPHY 
1.2.3. BY STAKEHOLDERS 
2. MARKET OVERVIEW AND INSIGHTS 
2.1. DEFINITION 
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS 
2.2.1. KEY FINDINGS 
2.2.2. RECOMMENDATION 
2.2.3. CONCLUSION 
2.3. REGULATIONS 
2.3.1. UNITED STATES 
2.3.2. EUROPEAN UNION 
2.3.3. CHINA 
2.3.4. INDIA 
2.3.5. REST OF THE WORLD 
2.4. PATENT ANALYSIS 

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3186924-global-bone-cancer-diagnosis-and-therapeutics-market-research

3. MARKET DETERMINANT 
3.1. MOTIVATORS 
3.1.1. ROBUST HEALTHCARE EXPENDITURE IN THE DEVELOPED ECONOMIES 
3.1.2. EXPOSURE TOWARDS RADIOACTIVE MATERIAL 
3.1.3. RISING GERIATRIC POPULATION 
3.1.4. INCREASING INCIDENCE OF PAGET DISEASES AMONG INDIVIDUALS 
3.1.5. STEM CELL TRANSPLANTS TECHNOLOGY 
3.2. RESTRAINTS 
3.2.1. LACK OF AWARNESS TOWARDS DIAGNOSIS AND THERAPEUTICS IN DEVELOPING AND UNDER DEVELPOED NATIONS 
3.2.2. HIGH COST OF TREATMENT 
3.3. OPPORTUNITIES 
3.3.1. R&D AND TECHNOLOGICAL ADVANCEMENT ON THE TREATMENT TECHNOLOGY 
4. MARKET SEGMENTATION 
4.1. GLOBAL BONE CANCER DIAGNOSIS AND THERAPEUTICS MARKET, BY TYPE 
4.1.1. PRIMARY BONE CANCER 
4.1.1.1. OSTEOSARCOMA 
4.1.1.2. CHONDROSARCOMA 
4.1.1.3. EWING’S SARCOMA 
4.1.1.4. SPINDEL CELL SARCOMA 
4.1.1.5. CHORDOMA 
4.1.2. SECONDARY BONE CANCER 
4.2. GLOBAL BONE CANCER DIAGNOSIS AND THERAPEUTICS MARKET, BY DIAGNOSIS 
4.2.1. MRI SCANS 
4.2.2. X-RAYS 
4.2.3. CT-SCAN 
4.2.4. RADIONUCLIDE BONE SENSORS 
4.2.5. BIOPSY 
4.2.6. OTHERS 
4.3. GLOBAL BONE CANCER DIAGNOSIS AND THERAPEUTICS MARKET, BY THERAPIES 
4.3.1. RADIATION THERAPIES 
4.3.2. CHEMOTHERAPHY 
4.3.3. CRYOSURGERY 
4.3.4. SURGICAL TREATMENT 
4.3.5. TARGETED THERAPHY 
4.3.6. OTHERS 
4.4. GLOBAL BONE CANCER DIAGNOSIS AND THERAPEUTICS MARKET, BY END USER 
4.4.1. MULTISPECIALITY HOSPITALS 
4.4.2. CANCER RESEARCH CENTERS 
5. COMPETITIVE LANDSCAPE 
5.1. STRATEGY ANALYSIS 
5.2. KEY COMPANY ANALYSIS 
6. REGIONAL ANALYSIS 
6.1. NORTH AMERICA 
6.1.1. UNITED STATES 
6.1.2. CANADA 
6.2. EUROPE 
6.2.1. UNITED KINGDOM 
6.2.2. FRANCE 
6.2.3. GERMANY 
6.2.4. ITALY 
6.2.5. SPAIN 
6.2.6. REST OF EUROPE 
6.3. ASIA PACIFIC 
6.3.1. INDIA 
6.3.2. CHINA 
6.3.3. JAPAN 
6.4. REST OF THE WORLD 
7. COMPANY PROFILES 
7.1. ABLYNZ 
7.2. ALLERGAN 
7.3. AVEO PHARMACEUTICALS, INC. 
7.4. AMGEN INC. 
7.5. AMURA HOLDINGS LTD. 
7.6. BAYER AG 
7.7. CATENA PHARMACEUTICALS INC. 

Continued…….

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Sol-Gel Coatings Global Industry 2018 Sales, Supply and Consumption Forecasts to 2025

PUNE, INDIA, May 25, 2018 /EINPresswire.com/ —

Global Sol-Gel Coatings Market

WiseGuyRerports.com Presents “Global Sol-Gel Coatings Market Research Report 2017” New Document to its Studies Database. The Report Contain 106 Pages With Detailed Analysis.

Description

Global Sol-Gel Coatings market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including 

3M Company 
Aspen Aerogels 
Cabot 
Chemat Technology 
Prinz Optics GmbH 
Gaema Tech 
Hybrid Glass Technologies 
MarkeTech International 
Nanogate AG 
NTC Nano Tech Coatings GmbH 

 

Get sample Report @ https://www.wiseguyreports.com/sample-request/1067481-global-sol-gel-coatings-market-research-report-2017

 

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Sol-Gel Coatings in these regions, from 2012 to 2022 (forecast), covering 
North America 
Europe 
China 
Japan 
Southeast Asia 
India 

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
Dip Coating 
Spray Coating 
Capillary Coating 
Spin Coating 
Flow Coating 
Roll Coating 

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Sol-Gel Coatings for each application, including 
Automobile 
Electronic Product 
Aerospace 
Construction

 

Complete Report Details @ https://www.wiseguyreports.com/reports/1067481-global-sol-gel-coatings-market-research-report-2017

 

Table of Contents -Major Key Points

Global Sol-Gel Coatings Market Research Report 2017 
1 Sol-Gel Coatings Market Overview 
1.1 Product Overview and Scope of Sol-Gel Coatings 
1.2 Sol-Gel Coatings Segment by Type (Product Category) 
1.2.1 Global Sol-Gel Coatings Production and CAGR (%) Comparison by Type (Product Category)(2012-2022) 
1.2.2 Global Sol-Gel Coatings Production Market Share by Type (Product Category) in 2016 
1.2.3 Dip Coating 
1.2.4 Spray Coating 
1.2.5 Capillary Coating 
1.2.6 Spin Coating 
1.2.7 Flow Coating 
1.2.8 Roll Coating 
1.3 Global Sol-Gel Coatings Segment by Application 
1.3.1 Sol-Gel Coatings Consumption (Sales) Comparison by Application (2012-2022) 
1.3.2 Automobile 
1.3.3 Electronic Product 
1.3.4 Aerospace 
1.3.5 Construction 
1.4 Global Sol-Gel Coatings Market by Region (2012-2022) 
1.4.1 Global Sol-Gel Coatings Market Size (Value) and CAGR (%) Comparison by Region (2012-2022) 
1.4.2 North America Status and Prospect (2012-2022) 
1.4.3 Europe Status and Prospect (2012-2022) 
1.4.4 China Status and Prospect (2012-2022) 
1.4.5 Japan Status and Prospect (2012-2022) 
1.4.6 Southeast Asia Status and Prospect (2012-2022) 
1.4.7 India Status and Prospect (2012-2022) 
1.5 Global Market Size (Value) of Sol-Gel Coatings (2012-2022) 
1.5.1 Global Sol-Gel Coatings Revenue Status and Outlook (2012-2022) 
1.5.2 Global Sol-Gel Coatings Capacity, Production Status and Outlook (2012-2022)

……………..

7 Global Sol-Gel Coatings Manufacturers Profiles/Analysis 
7.1 3M Company 
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.1.2 Sol-Gel Coatings Product Category, Application and Specification 
7.1.2.1 Product A 
7.1.2.2 Product B 
7.1.3 3M Company Sol-Gel Coatings Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
7.1.4 Main Business/Business Overview 
7.2 Aspen Aerogels 
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.2.2 Sol-Gel Coatings Product Category, Application and Specification 
7.2.2.1 Product A 
7.2.2.2 Product B 
7.2.3 Aspen Aerogels Sol-Gel Coatings Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
7.2.4 Main Business/Business Overview 
7.3 Cabot 
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.3.2 Sol-Gel Coatings Product Category, Application and Specification 
7.3.2.1 Product A 
7.3.2.2 Product B 
7.3.3 Cabot Sol-Gel Coatings Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
7.3.4 Main Business/Business Overview 
7.4 Chemat Technology 
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.4.2 Sol-Gel Coatings Product Category, Application and Specification 
7.4.2.1 Product A 
7.4.2.2 Product B 
7.4.3 Chemat Technology Sol-Gel Coatings Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
7.4.4 Main Business/Business Overview 
7.5 Prinz Optics GmbH 
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.5.2 Sol-Gel Coatings Product Category, Application and Specification 
7.5.2.1 Product A 
7.5.2.2 Product B 
7.5.3 Prinz Optics GmbH Sol-Gel Coatings Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 
7.5.4 Main Business/Business Overview 

 ……..CONTINUED

 

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Sulfuric Acid Market Opportunities by Key Players, Regional Segmentation and Forecasts, 2018 – 2023

PUNE, MAHARASHTRA, INDIA, May 25, 2018 /EINPresswire.com/ — Global Sulfuric Acid Industry

New Study on “2018-2023 Sulfuric Acid Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

The global sulfuric acid market is expected to grow at the CAGR of 4.1 % during 2018-2023. Sulfuric is a strong acid manufactured by oxidizing solutions of Sulfur-dioxide. In general, it is colorless, odorless liquid which is soluble in water and corrosive in nature. The market is showing a growth owing to increasing demand of the Sulfur based products, rising demand in industrial and fertilizer sector globally. It is mainly used in chemical manufacturing industry for making phosphate fertilizers automotive and pharmaceuticals. Additionally, sulfuric acid found a considerable utilization for sugar bleaching, paper bleaching, water treatment, cellulose fibers, coloring agents and so forth.

Try Sample Report @    https://www.wiseguyreports.com/sample-request/3186923-global-sulfuric-acid-market-research-and-forecast-2018-2023

The global sulfuric acid market has been segmented on the basis of manufacturing process, application, and type. By application, the market is divided into chemicals manufacturing, metal processing, textile industry, paper & sugar industry, automotive industry, fertilizer industry. The fertilizer industry will have a major market share across the globe. The fertilizer industry is increasing due to increasing usage of phosphate fertilizers in crops. By manufacturing processes, the market is divided in to contact process and wet sulfuric acid process. The contact process has a major market share due to wide spread acceptance of the technology. By type of acid, the market is divided into dilute and concentrated. Concentrated acid is expected to possess major market share due to its widespread application in industry such as producing phosphoric acid, in the production of fertilizers and so on.

Geographically, the market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America will show a lucrative growth for sulfuric acid in the near future. In Asia pacific, the major countries contributing to the market are China, India, and Japan. China is the largest player in Asia in chemical industry hence anticipated to contribute as a major market for sulfuric acid market. India is expected to show a significant growth in the manufacturing sector in the recent near future and hence expected to have a considerable market in the region.

The key players of global sulfuric acid market include: Akzonobel NV, Atul Ltd, BASF SE, Chevron and Solvay, Cytec industries, DuPont and Honeywell International. These companies are focusing on product innovations, expansions, and M&As, finding new market or innovate in their core competency in order to expand individual market share. Siemens is making use of sulfuric acid to make new generation blowers in order to increase the efficiency, reliability in usage, and reduction in space for their turbo-compressors. Similarly, DuPont’s innovation is the high performance catalytic converter by using Sulfuric acid, which is named as GEAR to reduce pressure drop and improve performance.

The report also includes detailed market overview, strategic recommendations, key company analysis, key findings, analyst insights, predictive analysis, patent analysis, pipeline analysis, market determinants, market segmentation and company profiling of the market.

Market Segmentation:

Global Sulfuric Acid is segmented on the basis of regional outlook and following segments:

Global Sulfuric Acid Market Research and Analysis, By Manufacturing Process 
Global Sulfuric Acid Market Research and Analysis, By Application 
Global Sulfuric Acid Market Research and Analysis, By Type 
Global Sulfuric Acid Market Research and Analysis, By Region 
The Report covers:

Comprehensive research methodology of Global Sulfuric Acid Market. 
This report also includes detailed and extensive market overview with key analyst insights. 
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. 
Analysis of regional regulations and other government policies impacting the Sulfuric Acid Market. 
Insights about market determinants which are stimulating the Sulfuric Acid Market. 
Detailed and extensive market segments with regional distribution of forecasted revenues. 
Extensive profiles and recent developments of market players.

 Some points from table of content:

1. REPORT SUMMARY 
1.1. RESEARCH METHODS AND TOOLS 
1.2. MARKET BREAKDOWN 
1.2.1. BY SEGMENTS 
1.2.2. BY GEOGRAPHY 
1.2.3. BY STAKEHOLDERS 
1.2.4. EXCEPTIONS 
2. MARKET OVERVIEW AND INSIGHTS 
2.1. DEFINITION 
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS 
2.2.1. KEY FINDINGS 
2.2.2. RECOMMENDATION 
2.2.3. CONCLUSION 
2.3. REGULATION 
2.3.1.1. UNITED STATES 
2.3.1.2. EUROPEAN UNION 
2.3.1.3. CHINA 
2.3.1.4. INDIA 

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3186923-global-sulfuric-acid-market-research-and-forecast-2018-2023

3. MARKET DETERMINANT 
3.1. MOTIVATORS 
3.1.1. INCREASING DEMAND IN AUTOMOBILE SECTOR (BATTERIES AND ELECTRIC VEHICLE) 
3.1.2. APPLICATION IN INDUSTRIAL WASTE WATER TREATMENT PLANT 
3.1.3. USAGE IN PHARMACEUTICALS, FERTILIZER (AGRICULTURE) MARKETS 
3.1.4. APPLICATION IN BLEACHING (PAPER & SUGAR INDUSTRY) 
3.1.5. GROWING DEMAND OF THE SULFUR BASED PRODUCTS (IN CELLULOSE FIBER, STEEL MANUFACTURING) 
3.2. RESTRAINT 
3.2.1. STRICT GOVERNMENT REGULATIONS 
3.2.2. ALTERNATIVE OF LEAD ACID BATTERY IN AUTOMOTIVE 
3.2.3. VOLATILITY IN PRICES OF RAW MATERIALS (SULFUR) 
3.2.4. SAFETY AND ENVIRONMENTAL CONCERN 
3.3. OPPORTUNITY 
3.3.1. TECHNOLOGICAL ADVANCEMENT AND INNOVATION IN CATALYST 
4. MARKET SEGMENTATION 
4.1. GLOBAL SULFURIC ACID MARKET RESEARCH AND ANALYSIS, BY APPLICATION 
4.1.1. CHEMICALS MANUFACTURING 
4.1.2. METAL PROCESSING 
4.1.3. TEXTILE INDUSTRY 
4.1.4. PAPER & SUGAR INDUSTRY 
4.1.5. AUTOMOTIVE INDUSTRY 
4.1.6. FERTILIZER INDUSTRY 
4.1.7. OTHER (POWER GENERATION) 
4.2. GLOBAL SULFURIC ACID MARKET RESEARCH AND ANALYSIS, BY MANUFACTURING PROCESSES 
4.2.1. CONTACT PROCESS 
4.2.2. WET SULFURIC ACID PROCESS 
4.2.3. OTHER (METABISULFITE METHOD AND MORE) 
4.3. GLOBAL SULFURIC ACID MARKET RESEARCH AND ANALYSIS, BY TYPE OF ACID 
4.3.1. DILUTE SULFURIC ACID 
4.3.2. CONCENTRATED SULFURIC ACID 
5. COMPETITIVE LANDSCAPE 
5.1. KEY STRATEGIES 
5.2. KEY COMPANY ANALYSIS 
6. REGIONAL ANALYSIS 
6.1. NORTH AMERICAN 
6.1.1. UNITED STATES 
6.1.2. CANADA 
6.2. EUROPE 
6.2.1. UK 
6.2.2. GERMANY 
6.2.3. SPAIN 
6.2.4. FRANCE 
6.2.5. ITALY 
6.3. APAC 
6.3.1. INDIA 
6.3.2. CHINA 
6.3.3. JAPAN 
6.3.4. REST OF APAC 
6.4. REST OF THE WORLD 
7. COMPANY PROFILES 
7.1. AGRIUM INC 
7.2. AKZO NOBEL N.V. 
7.3. ATUL LTD 
7.4. AURUBIS AG 
7.5. BASF SE 

Continued…….

For more information or any query mail at sales@wiseguyreports.com

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire